Skip to content
facebook
twitter
linkedin
THERADNET
International Network for Training and Innovation in Therapeutic Radiation
  • HOME
  • Network
    • EARLY STAGE RESEARCHERS
    • PARTNERS
    • MANAGEMENT TEAM
    • ASSOCIATED PARTNERS
    • ADVISORY BOARD
    • BENEFICIARY SITES
  • Science
    • Research Projects
      • TUMOR SENSITIZATION
      • NORMAL TISSUE PROTECTION
      • ADAPTATION AND ESCAPE
    • PUBLICATIONS
  • TRAININGS
  • Contact
  • Meetings & Workshops
    • MEETINGS
    • WORKSHOPS
  • Intranet

5- Metabolic reprograming of antioxidant defense: a precision medicine perspective for radiotherapy of lung cancer? (DOI: 10.1042/BST20200866)

4- Linking Serine/Glycine Metabolism to Radiotherapy Resistance (DOI: 10.3390/cancers13061191)

3- Mitochondrial Transfer in Cancer: A Comprehensive Review (DOI: 10.3390/ijms22063245)

2- Oncometabolites and the response to radiotherapy (DOI: 10.1186/s13014-020-01638-9)

1- Mitochondria in cancer (DOI: 10.15698/cst2020.06.221)

Funding

This project has received funding from the European Union’s Horizon 2020  research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860245

Contact

THERADNET
Martin Pruschy
Laboratory for Applied Radiobiology
Dept. of Radiation Oncology
University Hospital Zurich
theradnet@physiol.uzh.ch

Follow our blog

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

© 2021 THERADNET
 

Loading Comments...